1. Facts and Figures . Alzheimer’s disease and Dementia. https://www.alz.org/alzheimers-dementia/facts-figures. Accessed January 19, 2021.
Google Scholar2. Panegyres, PK, Chen, HY. the Coalition against Major Diseases (CAMD). Early-onset Alzheimer’s disease: a global cross-sectional analysis. Eur J Neurol. 2014;21(9):1149-e65. doi:10.1111/ene.12453.
Google Scholar | Crossref | Medline3. Mendez, MF . Early-onset Alzheimer disease. Neurol Clin. 2017;35(2):263-281. doi:10.1016/j.ncl.2017.01.005.
Google Scholar | Crossref | Medline4. Alzheimer’s Association . Early-onset Dementia: A National Challenge, a Future Crisis; 2006. alz.org/national/documents/report_earlyonset_summary.pdf. Accessed May 11, 2020.
Google Scholar5. Mendez, MF . The accurate diagnosis of early-onset dementia. Int J Psychiatry Med. 2006;36(4):401-412. doi:10.2190/Q6J4-R143-P630-KW41.
Google Scholar | SAGE Journals | ISI6. Wattmo, C, Wallin, ÅK. Early- versus late-onset Alzheimer’s disease in clinical practice: cognitive and global outcomes over 3 years. Alzheimer’s Res Ther. 2017;9(1):70. doi:10.1186/s13195-017-0294-2.
Google Scholar | Crossref | Medline7. Koedam, ELGE, Lauffer, V, van der Vlies, AE, van der Flier, WM, Scheltens, P, Pijnenburg, YAL. Early-versus late-onset Alzheimer’s Disease: more than age alone. J Alzheimers Dis. 2010;19(4):1401-1408. doi:10.3233/JAD-2010-1337.
Google Scholar | Crossref | Medline | ISI8. Filippi, M, Basaia, S, Canu, E, et al. Brain network connectivity differs in early-onset neurodegenerative dementia. Neurology. 2017;89(17):1764-1772. doi:10.1212/WNL.0000000000004577.
Google Scholar | Crossref | Medline9. Smith, R, Wibom, M, Olsson, T, et al. Posterior accumulation of tau and concordant hypometabolism in an early-onset Alzheimer’s Disease patient with presenilin-1 mutation. J Alzheimers Dis. 2016;51(2):339-343. doi:10.3233/JAD-151004.
Google Scholar | Crossref | Medline10. Filley, CM, Kelly, J, Heaton, RK. Neuropsychological features of early- and late-onset Alzheimer’s disease. Arch Neurol. 1986;43:574-576.
Google Scholar | Crossref | Medline11. Lundeen, TF, Seibyl, JP, Covington, MF, Eshghi, N, Kuo, PH. Signs and artifacts in amyloid PET. RadioGraphics. 2018;38(7):2123-2133. doi:10.1148/rg.2018180160.
Google Scholar | Crossref | Medline12. Jack, CR, Bennett, DA, Blennow, K, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535-562. doi:10.1016/j.jalz.2018.02.018.
Google Scholar | Crossref | Medline13. Canu, E, Agosta, F, Mandic-Stojmenovic, G, et al. Multiparametric MRI to distinguish early onset Alzheimer’s disease and behavioural variant of frontotemporal dementia. NeuroImage Clin. 2017;15:428-438. doi:10.1016/j.nicl.2017.05.018.
Google Scholar | Crossref | Medline14. Raji, CA, Ly, M, Benzinger, TLS. Overview of MR imaging volumetric quantification in neurocognitive disorders. Top Magn Reson Imaging. 2019;28(6):311-315. doi:10.1097/RMR.0000000000000224.
Google Scholar | Crossref | Medline15. Ahdidan, J, Raji, CA, DeYoe, EA, et al. Quantitative neuroimaging software for clinical assessment of hippocampal volumes on MR imaging. J Alzheimers Dis. 2015;49(3):723-732. doi:10.3233/JAD-150559.
Google Scholar | Crossref16. Meysami, S, Raji, CA, Merrill, DA, Porter, VR, Mendez, MF. MRI volumetric quantification in persons with a history of traumatic brain injury and cognitive impairment. J Alzheimers Dis. 2019;72(1):293-300. doi:10.3233/JAD-190708.
Google Scholar | Crossref | Medline17. McKhann, GM, Knopman, DS, Chertkow, H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263-269. doi:10.1016/j.jalz.2011.03.005.
Google Scholar | Crossref | Medline | ISI18. Daianu, M, Mendez, MF, Baboyan, VG, et al. An advanced white matter tract analysis in frontotemporal dementia and early-onset Alzheimer’s disease. Brain Imaging Behav. 2016;10(4):1038-1053. doi:10.1007/s11682-015-9458-5.
Google Scholar | Crossref | Medline19. Cohen, J . Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York. Lawrene Erlbaum Associates; 1988.
Google Scholar20. Benjamini, YHY . Controlling the false discovery rate: a practical and powerful approach to multiple testing. R Stat Soc. 1995;57:289-300.
Google Scholar | Crossref21. Migliaccio, R, Agosta, F, Possin, KL, et al. Mapping the progression of atrophy in early- and late-onset Alzheimer’s disease. J Alzheimers Dis. 2015;46(2):351-364. doi:10.3233/JAD-142292.
Google Scholar | Crossref | Medline22. Chiaravalloti, A, Koch, G, Toniolo, S, et al. Comparison between early-onset and late-onset Alzheimer’s disease patients with amnestic presentation: CSF and 18F-FDG PET study. Dement Geriatr Cogn Disord Extra. 2016;6(1):108-119. doi:10.1159/000441776.
Google Scholar | Crossref | Medline23. Frisoni, GB, Testa, C, Sabattoli, F, Beltramello, A, Soininen, H, Laakso, MP. Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry. 2005;76(1):112-114. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15608008.
Google Scholar | Crossref | Medline | ISI24. Frisoni, GB, Pievani, M, Testa, C, et al. The topography of grey matter involvement in early and late onset Alzheimer’s disease. Brain. 2007;130(3):720-730. doi:10.1093/brain/awl377.
Google Scholar | Crossref | Medline25. Holland, D, Desikan, RS, Dale, AM, McEvoy, LK, for the Alzheimer’s Disease Neuroimaging Initiative. Rates of decline in Alzheimer disease decrease with age. PLoS One. 2012;7(8):e42325. doi:10.1371/journal.pone.0042325.
Google Scholar | Crossref | Medline | ISI26. for the Alzheimer’s Disease Neuroimaging Initiative, Machado, A, Ferreira, D, et al. The cholinergic system in subtypes of Alzheimer’s disease: an in vivo longitudinal MRI study. Alzheimer's Res Ther. 2020;12(1):51. doi:10.1186/s13195-020-00620-7.
Google Scholar | Crossref | Medline27. Tellechea, P, Pujol, N, Esteve-Belloch, P, et al. Enfermedad de Alzheimer de inicio precoz y de inicio tardío: ¿son la misma entidad? Neurología. 2018;33(4):244-253. doi:10.1016/j.nrl.2015.08.002.
Google Scholar | Crossref | Medline28. Bulk, M, Abdelmoula, WM, Nabuurs, RJA, et al. Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer’s disease. Neurobiol Aging. 2018;62:231-242. doi:10.1016/j.neurobiolaging.2017.10.017.
Google Scholar | Crossref | Medline29. Tondo, G, Iaccarino, L, Caminiti, SP, et al. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer’s disease. Alzheimer's Res Ther. 2020;12(1):50. doi:10.1186/s13195-020-00619-0.
Google Scholar | Crossref | Medline30. Suppiah, S, Didier, M-A, Vinjamuri, S. The who, when, why, and how of PET amyloid imaging in management of Alzheimer’s disease—Review of literature and interesting images. Diagnostics. 2019;9(2):65. doi:10.3390/diagnostics9020065.
Google Scholar | Crossref31. La Joie, R, Visani, AV, Baker, SL, et al. Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12(524):eaau5732. doi:10.1126/scitranslmed.aau5732.
Google Scholar | Crossref | Medline32. Whitwell, JL, Martin, P, Graff-Radford, J, et al. The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer’s disease. Alzheimers Dement. 2019;15(5):675-685. doi:10.1016/j.jalz.2018.12.016.
Google Scholar | Crossref | Medline33. Desikan, RS, Rafii, MS, Brewer, JB, Hess, CP. An expanded role for neuroimaging in the evaluation of memory impairment. AJNR Am J Neuroradiol. 2013;34(11):2075-2082. doi:10.3174/ajnr.A3644.
Google Scholar | Crossref | Medline34. McEvoy, LK, Brewer, JB. Quantitative structural MRI for early detection of Alzheimer’s disease. Expert Rev Neurother. 2010;10(11):1675-1688. doi:10.1586/ern.10.162.
Google Scholar | Crossref | Medline35. Caso, F, Agosta, F, Mattavelli, D, et al. White matter degeneration in atypical Alzheimer disease. Radiology. 2015;277(1):162-172. doi:10.1148/radiol.2015142766.
Google Scholar | Crossref | Medline36. Canu, E, Agosta, F, Spinelli, EG, et al. White matter microstructural damage in Alzheimer’s disease at different ages of onset. Neurobiol Aging. 2013;34(10):2331-2340. doi:10.1016/j.neurobiolaging.2013.03.026.
Google Scholar | Crossref | Medline37. Nestor, SM, Rupsingh, R, Borrie, M, et al. Ventricular enlargement as a possible measure of Alzheimer’s disease progression validated using the Alzheimer’s disease neuroimaging initiative database. Brain. 2008;131(9):2443-2454. doi:10.1093/brain/awn146.
Google Scholar | Crossref | Medline38. de Flores, R, La Joie, R, Chételat, G. Structural imaging of hippocampal subfields in healthy aging and Alzheimer’s disease. Neuroscience. 2015;309:29-50. doi:10.1016/j.neuroscience.2015.08.033.
Google Scholar | Crossref | Medline39. Jack, CR, Bennett, DA, Blennow, K, et al. A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87(5):539-547. doi:10.1212/WNL.0000000000002923.
Google Scholar | Crossref | Medline40. Vos, SJB, Duara, R. The prognostic value of ATN Alzheimer biomarker profiles in cognitively normal individuals. Neurology. 2019;92(14):643-644. doi:10.1212/WNL.0000000000007223.
Google Scholar | Crossref | Medline